Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections-Reference-Cited by-同舟云学术

Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections

Published:2015-09 Issue:3 Volume:46 Page:266-271
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Liscio Jordan L.,Mahoney Monica V.,Hirsch Elizabeth B.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference40 articles.

1. Report reveals scope of US antibiotic resistance threat;Hampton;J Am Med Assoc,2013

2. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010;Sievert;Infect Control Hosp Epidemiol,2013

3. Extended-spectrum β-lactamases: a clinical update;Paterson;Clin Microbiol Rev,2005

4. Updated functional classification of β-lactamases;Bush;Antimicrob Agents Chemother,2010

5. β-Lactamase inhibitors: the story so far;Pérez-Llarena;Curr Med Chem,2009

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutations Leading to Ceftolozane/Tazobactam and Imipenem/Cilastatin/Relebactam Resistance Duringin vivoexposure to Ceftazidime/Avibactam inPseudomonas aeruginosa;2024-09-10

2. In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance;Journal of Global Antimicrobial Resistance;2024-09

3. In vitro activity of cefiderocol against carbapenemase-producing and meropenem-nonsusceptible gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance (JARBS-GNR);2024-02-15

4. Identification of α-mangostin as a potent inhibitor of β-lactamase OXA-48;Medicinal Chemistry Research;2024-01-10

5. Optimized Treatment of Nosocomial Peritonitis;Antibiotics;2023-12-08